Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

NYSE:KRO - New York Stock Exchange, Inc. - US50105F1057 - Common Stock - Currency: USD

7.59  -0.09 (-1.17%)

After market: 7.59 0 (0%)

Fundamental Rating

5

Overall KRO gets a fundamental rating of 5 out of 10. We evaluated KRO against 85 industry peers in the Chemicals industry. KRO has an average financial health and profitability rating. KRO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

KRO had positive earnings in the past year.
KRO had a positive operating cash flow in the past year.
KRO had positive earnings in 4 of the past 5 years.
KRO had a positive operating cash flow in each of the past 5 years.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

KRO's Return On Assets of 4.50% is fine compared to the rest of the industry. KRO outperforms 74.12% of its industry peers.
Looking at the Return On Equity, with a value of 10.55%, KRO is in the better half of the industry, outperforming 75.29% of the companies in the same industry.
KRO has a Return On Invested Capital of 6.67%. This is in the better half of the industry: KRO outperforms 65.88% of its industry peers.
Industry RankSector Rank
ROA 4.5%
ROE 10.55%
ROIC 6.67%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

KRO's Profit Margin of 4.57% is fine compared to the rest of the industry. KRO outperforms 64.71% of its industry peers.
In the last couple of years the Profit Margin of KRO has declined.
KRO has a worse Operating Margin (6.43%) than 60.00% of its industry peers.
In the last couple of years the Operating Margin of KRO has declined.
With a Gross Margin value of 19.04%, KRO is not doing good in the industry: 67.06% of the companies in the same industry are doing better.
KRO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.43%
PM (TTM) 4.57%
GM 19.04%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KRO is destroying value.
Compared to 1 year ago, KRO has about the same amount of shares outstanding.
KRO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for KRO is higher compared to a year ago.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

KRO has an Altman-Z score of 1.92. This is not the best score and indicates that KRO is in the grey zone with still only limited risk for bankruptcy at the moment.
KRO has a Altman-Z score of 1.92. This is comparable to the rest of the industry: KRO outperforms 55.29% of its industry peers.
The Debt to FCF ratio of KRO is 11.80, which is on the high side as it means it would take KRO, 11.80 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.80, KRO perfoms like the industry average, outperforming 56.47% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that KRO is somewhat dependend on debt financing.
KRO's Debt to Equity ratio of 0.53 is in line compared to the rest of the industry. KRO outperforms 57.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 11.8
Altman-Z 1.92
ROIC/WACC0.74
WACC9.02%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.32 indicates that KRO has no problem at all paying its short term obligations.
The Current ratio of KRO (2.32) is better than 67.06% of its industry peers.
KRO has a Quick Ratio of 2.32. This is a bad value and indicates that KRO is not financially healthy enough and could expect problems in meeting its short term obligations.
KRO has a Quick ratio (0.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.94
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 141.86% over the past year.
The earnings per share for KRO have been decreasing by -24.83% on average. This is quite bad
The Revenue has grown by 13.24% in the past year. This is quite good.
KRO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.74% yearly.
EPS 1Y (TTM)141.86%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-140%
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%5.75%

3.2 Future

KRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 99.26% yearly.
Based on estimates for the next years, KRO will show a small growth in Revenue. The Revenue will grow by 2.83% on average per year.
EPS Next Y402.19%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
EPS Next 5YN/A
Revenue Next Year1.96%
Revenue Next 2Y4.62%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.17, KRO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, KRO is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of KRO to the average of the S&P500 Index (28.87), we can say KRO is valued slightly more expensively.
KRO is valuated reasonably with a Price/Forward Earnings ratio of 8.40.
Based on the Price/Forward Earnings ratio, KRO is valued cheaper than 84.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KRO to the average of the S&P500 Index (21.38), we can say KRO is valued rather cheaply.
Industry RankSector Rank
PE 42.17
Fwd PE 8.4
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRO is valued a bit cheaper than 75.29% of the companies in the same industry.
65.88% of the companies in the same industry are more expensive than KRO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.31
EV/EBITDA 6.92
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

KRO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KRO's earnings are expected to grow with 99.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y157.32%
EPS Next 3Y99.26%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.59%, KRO has a reasonable but not impressive dividend return.
The stock price of KRO dropped by -20.86% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
KRO's Dividend Yield is a higher than the industry average which is at 3.80.
KRO's Dividend Yield is comparable with the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 2.59%

5.2 History

The dividend of KRO decreases each year by -7.80%.
KRO has paid a dividend for at least 10 years, which is a reliable track record.
KRO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years13
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

KRO pays out 64.04% of its income as dividend. This is not a sustainable payout ratio.
DP64.04%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (4/28/2025, 8:20:52 PM)

After market: 7.59 0 (0%)

7.59

-0.09 (-1.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners16.2%
Inst Owner Change0.28%
Ins Owners0.11%
Ins Owner Change0.04%
Market Cap873.15M
Analysts46
Price Target10.2 (34.39%)
Short Float %3.54%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield 2.59%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP64.04%
Div Incr Years0
Div Non Decr Years13
Ex-Date03-11 2025-03-11 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-132.5%
Min EPS beat(2)-188.88%
Max EPS beat(2)-76.11%
EPS beat(4)2
Avg EPS beat(4)128.2%
Min EPS beat(4)-188.88%
Max EPS beat(4)766.34%
EPS beat(8)3
Avg EPS beat(8)-0.85%
EPS beat(12)5
Avg EPS beat(12)-2.79%
EPS beat(16)7
Avg EPS beat(16)-3.24%
Revenue beat(2)0
Avg Revenue beat(2)-15.49%
Min Revenue beat(2)-15.74%
Max Revenue beat(2)-15.25%
Revenue beat(4)1
Avg Revenue beat(4)-9.16%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)3.09%
Revenue beat(8)3
Avg Revenue beat(8)-3.87%
Revenue beat(12)6
Avg Revenue beat(12)-1.44%
Revenue beat(16)8
Avg Revenue beat(16)-1.25%
PT rev (1m)-16.67%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.96%
EPS NY rev (1m)0%
EPS NY rev (3m)6.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)-4.3%
Revenue NY rev (3m)-4.3%
Valuation
Industry RankSector Rank
PE 42.17
Fwd PE 8.4
P/S 0.46
P/FCF 20.31
P/OCF 12.04
P/B 1.07
P/tB 1.07
EV/EBITDA 6.92
EPS(TTM)0.18
EY2.37%
EPS(NY)0.9
Fwd EY11.91%
FCF(TTM)0.37
FCFY4.92%
OCF(TTM)0.63
OCFY8.3%
SpS16.4
BVpS7.1
TBVpS7.08
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.5%
ROE 10.55%
ROCE 8.44%
ROIC 6.67%
ROICexc 7.2%
ROICexgc 7.22%
OM 6.43%
PM (TTM) 4.57%
GM 19.04%
FCFM 2.28%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 11.8
Debt/EBITDA 2.31
Cap/Depr 45.81%
Cap/Sales 1.56%
Interest Coverage 3.18
Cash Conversion 39.04%
Profit Quality 49.88%
Current Ratio 2.32
Quick Ratio 0.94
Altman-Z 1.92
F-Score6
WACC9.02%
ROIC/WACC0.74
Cap/Depr(3y)85.77%
Cap/Depr(5y)95.93%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-140%
EPS Next Y402.19%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
EPS Next 5YN/A
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%5.75%
Revenue Next Year1.96%
Revenue Next 2Y4.62%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y302.5%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year71.04%
EBIT Next 3Y30.35%
EBIT Next 5YN/A
FCF growth 1Y202.63%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y1218.18%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%